Be part of the knowledge.™

New Drug for Diabetic Patients in Phase 2 Trials

Media Formats

ReachMD Healthcare Image

Ready to Claim Your Credits?

You have attempts to pass this post-test. Take your time and review carefully before submitting.

Good luck!

Details

Presenters

Overview
Dr. Berkowitz, President and CEO of Alteon, Inc. discusses a new drug that they are developing for diabetic patients.

Noah Berkowitz, MD

Noah Berkowitz, MD

Shira Johnson, MD

Shira Johnson, MD

Recommended

Details

Presenters

Overview
Dr. Berkowitz, President and CEO of Alteon, Inc. discusses a new drug that they are developing for diabetic patients.

Noah Berkowitz, MD

Noah Berkowitz, MD

Shira Johnson, MD

Shira Johnson, MD

Program Chapters

Segment Chapters

Playlist:

Recommended

Innovations in the Management of Hemolytic Disease of the Fetus and Newborn: The Role of the Neonatal Fc Receptor (FcRn) Pathway

M3: Managing the Cardiometabolic Risk in MASH

Maximizing Adherence and Persistence via Patient Engagement

CME/CE Broadcast Replay

Love Story: Lipid Education for Women’s Heart Health

HF Management for Patients with Comorbid Conditions

Clinical Conundrums in ARIA: Communicating ARIA Risk with Patients Considering Anti-Aβ Therapy

Navigating Myasthenia Gravis in Adolescents and Young Adults

Rozanolixizumab for Myasthenia Gravis: An Alternative to Corticosteroids